Welcome to the new version of CaltechAUTHORS. Login is currently restricted to library staff. If you notice any issues, please email coda@library.caltech.edu
Published April 9, 1991 | public
Journal Article

ADRla, a zinc finger peptide, exists in two folded conformations

Abstract

Two-dimensional N MR (2DNMR) studies of several different zinc finger peptides have yielded a picture of the three-dimensional structure of this small DNA-binding motif. Details of the differences among fingers with different sequences may provide some insight into how these domains interact with DNA. Toward this end, we have reanalyzed the 2DNMR spectra of the C-terminal zinc finger sequence from the yeast transcriptional factor ADRl. Although this was the sequence on which our original report describing the overall fold of zinc fingers was based, complete spectral assignments (reported here) were needed to compare this sequence in detail with that of ADRlb, for which we have reported an atomic level structure. In the process of analyzing the spectra of ADRla and a mutant of ADRla, it was noted that the peptides give two sets of NMR lines, indicating that this sequence, unlike the other ADRl zinc finger sequence, exists in two slowly interconverting folded conformations in solution. Residues that exhibit peak doubling are located in the Cys loop, the a-helix, and the extreme C-terminus of the peptide. Differences in NOES observed for the two forms indicate that there are detectable conformational differences in the Zn^(2+) cluster and in the fingertip region. This conformational flexibility, which has not been observed for other zinc finger peptides, may stem from the presence of an additional residue between the histidine ligands (His-X_4-His versus His-X_3-His).

Additional Information

© 1991 American Chemical Society. Received August 10, 1990; Revised Manuscript Received December 27, 1990. This work was supported by NIH Grant PO1 GM32681. R.E.K. was supported by an American Heart Association Established Investigatorship. We thank Dr. Jon Herriott for reading the manuscript.

Additional details

Created:
August 19, 2023
Modified:
October 18, 2023